U.S.-Based PPD Inks Deal With Peking Biomedical, Expands Lab Services
This article was originally published in PharmAsia News
U.S.-based Pharmaceutical Product Development inked an exclusive deal with Peking Union Lawke Biomedical Development Limited to expand its global central lab services in China, the company announced Jan. 23
You may also be interested in...
SHANGHAI - The global contract research organization PPD has signed an agreement to acquire Excel PharmaStudies, a leading CRO in China, to upgrade its research capability across Asia, the company announced Oct. 27
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).